Levi & Korsinsky, LLP has announced a securities class action lawsuit against Veritone, Inc. (NASDAQ: VERI) for investors who purchased securities between October 14, 2025, and April 14, 2026. The lawsuit alleges that Veritone made misrepresentations about barter revenue and agent-vs.-principal accounting, leading to an overstatement of financial results. Investors who suffered losses may be entitled to compensation and have until July 20, 2026, to seek lead plaintiff status.

Omnicom Group Inc. shares are trading in the low-$70s on the New York Stock Exchange, with Wall Street analysts maintaining a "Hold" consensus despite seeing double-digit percentage upside potential over the next 12 months. The stock experienced a modest decline of about 7.4% since the start of 2026, though it saw a 3.2% intraday gain on May 30, 2026. The company, with a market capitalization of approximately $20.7 billion, is a major player in advertising and marketing services globally.

Dow Inc. (DOW) has announced a long-term partnership with Univar Solutions to expand the distribution of its Decarbia low-carbon product line across beauty, food, and pharmaceutical sectors. This strategic collaboration aims to meet the increasing demand for sustainable raw materials and help customers with carbon-footprint documentation. Despite Dow's moderate GF Score™ and financial strength concerns, this partnership signifies its commitment to sustainable solutions and capitalizing on market opportunities in eco-friendly products.

The seemingly endless rally in space-related companies is showing signs of weakening as the IPO of Elon Musk's SpaceX approaches. Several rocket stocks, including the Procure Space ETF (UFO), Intuitive Machines Inc., Rocket Lab Corp., and AST SpaceMobile Inc., have experienced significant drops over two sessions. This downturn suggests investor apprehension or a shift in market dynamics ahead of SpaceX's public debut.

Nordson Corporation's stock (NDSN) traded near USD 287 in late May after the company reported stronger-than-expected quarterly results and raised its guidance for both Q3 2026 and the full fiscal year. While analysts maintain a "Moderate Buy" stance with an average price target of USD 311.29, recent data highlights both institutional and insider selling activity, indicating some investors are adjusting their holdings. The company, a key player in industrial technology, continues to be closely watched amidst its performance and market dynamics.

Centene Corporation (NYSE:CNC) is highlighted as one of the top stocks to buy according to AI, ranking 8th on a list of best AI-backed investments. The healthcare enterprise, primarily focused on government-sponsored and commercial managed care programs, reported strong Q1 2026 earnings, surpassing consensus estimates with $49.94 billion in revenue and adjusted diluted EPS of $3.37. Centene's success is attributed to robust premium yields, strategic state contracts, and efficient cost management.

The 2026 crypto market is seeing significant institutional expansion and on-chain activity, with Solana gaining attention due to accelerating ETF filings and over $1 trillion in Q1 on-chain volume. While large-cap ecosystems attract institutional capital, early-stage platforms like MemeToro are also gaining traction. MemeToro, an AI-driven memecoin presale, offers a unified ecosystem for creating, trading, and analyzing memecoins, attracting investors seeking early market entry and sustained utility beyond the presale phase.

Eli Lilly and Company (LLY) is highlighted as one of the top stocks to buy according to AI, ranking 4th on Insider Monkey's list. The pharmaceutical giant's growth is primarily driven by its cardiometabolic health portfolio, featuring successful drugs like Mounjaro and Zepbound. The company reported strong Q1 2026 financial results with significant revenue and EPS growth, leading management to raise full-year guidance.

This article identifies stocks that exhibited unusual trading volume on Monday, June 1, 2026. Ten stocks are highlighted, including ZHONGCHAO INC-CLASS A (ZCMD) with a 4000% increase in volume and a 55.39% price drop, and GENENTA SCIENCE SPA - ADR (GNTA) with a 22,000% increase in volume and a 77.56% price increase. The report provides a brief analysis for each stock, noting their respective price changes and relative volume compared to their 50-day average.

Hormel Foods reported mixed results for Q2 fiscal 2026, with retail sales remaining flat and a 2% volume decline due to a challenging retail environment and underperforming brands like Planters and Skippy. In contrast, its Foodservice unit saw sales increase by 6% and operating income climb by 11%. Overall, Hormel's earnings dropped 12% to $158 million, though the company reaffirmed its full-year sales guidance despite anticipating near-term cost pressures and higher logistics expenses.